Sinopharm
1099.HK
#2340
Rank
โ‚น703.65 B
Marketcap
โ‚น225.48
Share price
-0.81%
Change (1 day)
-3.04%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.189 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.189 Trillion. In 2024 the company made a revenue of โ‚น7.189 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.576 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.189 T-5.1%
2023โ‚น7.576 T5.42%
2022โ‚น7.186 T-2.1%
2021โ‚น7.340 T16.85%
2020โ‚น6.282 T14.95%
2019โ‚น5.465 T21.52%
2018โ‚น4.497 T5.93%
2017โ‚น4.245 T27.22%
2016โ‚น3.336 T5.37%
2015โ‚น3.166 T9.14%
2014โ‚น2.901 T17.22%
2013โ‚น2.475 T25.94%
2012โ‚น1.965 T34.61%
2011โ‚น1.460 T55.34%
2010โ‚น939.92 B35.79%
2009โ‚น692.20 B37.56%
2008โ‚น503.21 B31.43%
2007โ‚น382.88 B40.26%
2006โ‚น272.97 B